• Je něco špatně v tomto záznamu ?

Expression of p53 and p53/47 are controlled by alternative mechanisms of messenger RNA translation initiation

MM Candeias, DJ Powell, E Roubalova, S Apcher, K Bourougaa, B Vojtesek, H Bruzzoni-Giovanelli, R Fahraeus

. 2006 ; 25 (52) : 6936-6947.

Jazyk angličtina Země Velká Británie

Typ dokumentu práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc13032368

Grantová podpora
NR8338 MZ0 CEP - Centrální evidence projektů

Digitální knihovna NLK
Plný text - Článek
Zdroj

E-zdroje Online Plný text

NLK ProQuest Central od 2000-01-01 do Před 1 rokem
Open Access Digital Library od 1997-01-01
Medline Complete (EBSCOhost) od 1997-01-09 do 2015-11-26
Health & Medicine (ProQuest) od 2000-01-01 do Před 1 rokem
Public Health Database (ProQuest) od 2000-01-01 do Před 1 rokem

P53 controls the growth and survival of cells by acting in response to a multitude of cellular stresses. It is, however, not yet fully understood how different p53 activation pathways result in either cell cycle arrest or apoptosis. We and others have described an N-terminally truncated p53 protein (p53/47) originating from a second translation initiation site in the p53 messenger RNA (mRNA), which can interact with p53 and impose altered stability and transactivation properties to p53 complexes. Here we show that cap-dependent and cap-independent mechanisms of initiation govern the translation of the p53 mRNA. Changes in synthesis of full-length p53 or p53/47 are regulated through distinct cell stress-induced pathways acting through separate regions of the p53 mRNA. We also show that some cytotoxic drugs require the presence of full-length p53 to induce apoptosis, whereas for others p53/47 is sufficient. This indicates that by harbouring alternative translation initiation sites, the p53 mRNA gives rise to different levels of the p53 isoforms which help to orchestrate the cell biological outcome of p53 activation in response to different types of cell stress. This sheds new light into the way p53 can integrate and differentiate a large multiplicity of changes in the cellular environment.

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc13032368
003      
CZ-PrNML
005      
20131211100317.0
007      
ta
008      
131007s2006 xxk f 000 0|eng||
009      
AR
035    __
$a (PubMed)16983332
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xxk
100    1_
$a Candeias, M. M. $u Inserm U716, Institut de Genetique Moleculaire, Hopital St Louis, Paris, France.
245    10
$a Expression of p53 and p53/47 are controlled by alternative mechanisms of messenger RNA translation initiation / $c MM Candeias, DJ Powell, E Roubalova, S Apcher, K Bourougaa, B Vojtesek, H Bruzzoni-Giovanelli, R Fahraeus
504    __
$a Literatura
520    9_
$a P53 controls the growth and survival of cells by acting in response to a multitude of cellular stresses. It is, however, not yet fully understood how different p53 activation pathways result in either cell cycle arrest or apoptosis. We and others have described an N-terminally truncated p53 protein (p53/47) originating from a second translation initiation site in the p53 messenger RNA (mRNA), which can interact with p53 and impose altered stability and transactivation properties to p53 complexes. Here we show that cap-dependent and cap-independent mechanisms of initiation govern the translation of the p53 mRNA. Changes in synthesis of full-length p53 or p53/47 are regulated through distinct cell stress-induced pathways acting through separate regions of the p53 mRNA. We also show that some cytotoxic drugs require the presence of full-length p53 to induce apoptosis, whereas for others p53/47 is sufficient. This indicates that by harbouring alternative translation initiation sites, the p53 mRNA gives rise to different levels of the p53 isoforms which help to orchestrate the cell biological outcome of p53 activation in response to different types of cell stress. This sheds new light into the way p53 can integrate and differentiate a large multiplicity of changes in the cellular environment.
590    __
$a bohemika - dle Pubmed
650    02
$a 5' nepřekládaná oblast $7 D020121
650    02
$a northern blotting $7 D015152
650    02
$a nádorové buněčné linie $7 D045744
650    02
$a průtoková cytometrie $7 D005434
650    02
$a exprese genu $7 D015870
650    12
$a regulace genové exprese $x genetika $7 D005786
650    02
$a lidé $7 D006801
650    12
$a proteosyntéza $x fyziologie $7 D014176
650    12
$a protein - isoformy $x genetika $7 D020033
650    12
$a messenger RNA $x metabolismus $7 D012333
650    02
$a polymerázová řetězová reakce s reverzní transkripcí $7 D020133
650    12
$a nádorový supresorový protein p53 $x genetika $7 D016159
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Powell, D. J.
700    1_
$a Roubalová, Eva $7 _AN058771 $u Masaryk Memorial Cancer Institut, Brno, Czech Republic
700    1_
$a Apcher, S. $7 gn_A_00007759
700    1_
$a Bourougaa, K.
700    1_
$a Vojtěšek, Bořivoj, $d 1960- $7 xx0001694 $u Masaryk Memorial Cancer Institut, Brno, Czech Republic
700    1_
$a Bruzzoni-Giovanelli, H.
700    1_
$a Fahraeus, R.
773    0_
$t Oncogene $x 0950-9232 $g Roč. 25, č. 52 (2006), s. 6936-6947 $p Oncogene $w MED00003600
773    0_
$p Oncogene $g 25(52):6936-47, 2006 Nov 2 $x 0950-9232
910    __
$a ABA008 $b B 1746 $y 4 $z 0
990    __
$a 20131007154248 $b ABA008
991    __
$a 20131211100959 $b ABA008
999    __
$a ok $b bmc $g 996474 $s 830818
BAS    __
$a 3
BMC    __
$a 2006 $b 25 $c 52 $d 6936-6947 $i 0950-9232 $m Oncogene $x MED00003600 $n Oncogene
GRA    __
$a NR8338 $p MZ0
LZP    __
$a 2013-10/dpbo

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace